|
2025
|
Invention
|
Immediate release multilayer tablet.
Described herein, in part, are tablets, such as immediate r... |
|
|
Invention
|
Pharmaceutical compositions having improved storage stability.
The present invention relates to ... |
|
|
Invention
|
Aripiprazole dosing strategy.
The present invention relates to methods of treating schizophrenia... |
|
2024
|
Invention
|
Heterocyclic compounds for the treatment of neurological and psychological disorders.
Lactam com... |
|
|
Invention
|
Prodrugs of fumarates and their use in treating various diseases.
The present invention provides... |
|
|
Invention
|
Monomethylfumarate prodrug compositions.
The present invention provides pharmaceutical compositi... |
|
|
Invention
|
Pharmaceutical compositions having improved storage stability. The present invention relates to a... |
|
|
Invention
|
Aripiprazole formulations having increased injection speeds.
The present invention relates to ph... |
|
|
Invention
|
Sustained release aminopyridine composition.
A pharmaceutical composition which comprises a ther... |
|
2023
|
Invention
|
Crystallization process of aripiprazole derivatives in extended release formulations for treatmen... |
|
|
Invention
|
Immediate release multilayer tablet. Described herein, in part, are tablets, such as immediate re... |
|
|
Invention
|
Pharmaceutical compositions comprising sorbitan esters.
The present invention relates to a pharm... |
|
|
Invention
|
Methods for treating antipsychotic-induced weight gain. The present invention relates to the disc... |
|
|
Invention
|
Prodrugs of fumarates and their use in treating various diseases. The present invention provides ... |
|
|
Invention
|
Crystalline forms of naltrexone. This disclosure provides crystalline forms of naltrexone, and me... |
|
|
Invention
|
Compositions and methods for cancer immunotherapy. The disclosure provides compositions and impro... |
|
2022
|
Invention
|
Methods for treating depressive symptoms. The present application relates methods for treating a ... |
|
|
Invention
|
Heterocyclic compounds for the treatment of neurological and psychological disorders. Lactam comp... |
|
|
Invention
|
Methods of administering intravenous meloxicam in a bolus dose.
The present disclosure relates t... |
|
|
Invention
|
Aripiprazole formulations having increased injection speeds. The present invention relates to pha... |
|
|
Invention
|
Sustained release aminopyridine composition. A pharmaceutical composition which comprises therape... |
|
|
Invention
|
Aripiprazole dosing strategy. The present invention relates to methods of treating schizophrenia ... |
|
2021
|
P/S
|
Logistics management in the field of medication, namely, business services in the nature of suppo... |
|
|
Invention
|
Reduction of flake-like aggregation in nanoparticulate active agent compositions. This invention ... |
|
|
Invention
|
Aripiprazole prodrug composition.
Described is a composition comprising (a) a population of part... |
|
|
Invention
|
Il-2 fusion polypeptide compositions and methods of making and using the same. Provided herein ar... |
|
|
Invention
|
Naltrexone long acting formulations and methods of use.
The inventions described herein arose fr... |
|
|
Invention
|
Immunostimulatory agents in combination with angiogenesis inhibitors. The invention provides comp... |
|
2020
|
Invention
|
Compositions of buprenorphine and µ antagonists.
The invention relates to a composition comprisi... |
|
2019
|
P/S
|
Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and d... |
|
|
Invention
|
Methods of administering intravenous meloxicam pre-operatively and in combination with other drug... |
|
|
P/S
|
Providing awareness programs in the nature of educational presentations for health care practitio... |
|
|
P/S
|
Providing educational information in the field of schizophrenia Providing a website featuring emo... |
|
2018
|
P/S
|
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients... |
|
2017
|
P/S
|
Pharmaceutical preparations for the treatment of diseases mediated by an opioid receptor, namely,... |
|
|
P/S
|
Pharmaceuticals, namely, prodrugs and chemical derivatives
of pharmaceutically active ingredient... |
|
|
P/S
|
Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active in... |
|
2010
|
P/S
|
Protein fusion compounds; fusion compounds for the delivery of pharmaceuticals; derivatives of th... |
|
|
P/S
|
Pharmaceutical compounds; protein fusion compounds; fusion
compounds for the delivery of pharmac... |
|
2008
|
P/S
|
Milling media being metal or metal alloy pellets/beads for use in the manufacture of pharmaceutic... |
|
|
P/S
|
Pharmaceutical preparations, namely, a drug delivery system comprising a polymer-based matrix, in... |
|
2006
|
P/S
|
Synthetic biodegradable polymers for use in the manufacture of [ surgical sutures, surgical stapl... |
|
2005
|
P/S
|
Polystyrene milling media for the fine particulate grinding of pharmaceuticals |
|
2004
|
P/S
|
Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets... |
|
2000
|
P/S
|
Pharmaceutical formulations, namely compounds (to formulas), substances and preparations. Pharmac... |
|
|
P/S
|
Machinery used to create particulate matter. |
|
1999
|
P/S
|
Controlled multidirectional release pellets or beads contained in tablets or capsules containing ... |
|
|
P/S
|
Tablet matrix used to improve the solubility and absorption characteristics of poorly water solub... |
|
1998
|
P/S
|
Pharmaceutical preparations, including ingredients and components thereof; veterinary and sanitar... |
|
|
P/S
|
Pharmaceutical preparations, namely, adjuvant preparations sold as a component of a full line of ... |
|
1997
|
P/S
|
Polymers and polymer materials; chemicals and polymers for use in the pharmaceutical industry. Po... |
|
1996
|
P/S
|
polymer-based drug delivery formulations for clinical use |
|
1993
|
P/S
|
Pharmaceutical preparations, namely ultra small particle technology. |
